Target intelligence / Profile preview

EPS8 signaling adaptor L1 (EPS8L1)

Target
EPS8L1
Molecular classification
Adapter protein (signaling adaptor), Cytoskeletal associated protein, Other (not classified as receptor, enzyme, transporter, or ion channel)
01

Overview

EPS8 signaling adaptor L1 (EPS8L1) is a cytoskeletal-associated signaling adapter protein related to EPS8, which is a substrate for the epidermal growth factor receptor (EGFR)[3][6]. EPS8L1 is part of a family of proteins that mediate signal transduction from receptor tyrosine kinases (RTKs) to the actin cytoskeleton, primarily through interaction with other proteins such as Abi1 and Sos-1, and is involved in actin remodeling and membrane ruffling in response to growth factor stimulation[1]. Like EPS8, EPS8L1 contains an SH3 (Src homology 3) domain and a conserved C-terminal region important for binding with F-actin, suggesting a role in cytoskeleton organization and dynamic cell structures[1][3]. However, the detailed function and physiological role of EPS8L1 remain incompletely determined. It is not currently recognized as a therapeutic target, and there are no known drugs or direct mechanistic interventions for this protein[3][6]. EPS8L1 is associated with genetic disorders such as fetal akinesia deformation sequence and may play a role in cancer biology, but it is not itself a clinical biomarker or target for drug therapy at this time[3][4]. Functional redundancy within the EPS8 protein family suggests that loss of EPS8L1 can be compensated by related proteins[1][3].

Other names
EPS8L1EPS8-like 1 proteinEpidermal growth factor receptor pathway substrate 8-like protein 1Q8TE68 (UniProt ID)
02

Mechanism of action

Not applicable; no drugs target EPS8L1 directly

03

Biological functions

Actin binding and cytoskeletal remodelingStimulation of guanine nucleotide exchange factor activity (via SOS1)Signal transduction related to growth factor pathwaysMembrane ruffling and cell migration
04

Disease associations

Some association with cancer (noted in neoplasm context)Fetal akinesia deformation sequence 4Villous adenocarcinomaOther (i.e., possible but not definitive links to disease)

Beyond the preview

Go deeper on EPS8 signaling adaptor L1 (EPS8L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EPS8 signaling adaptor L1 (EPS8L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call